Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Abstracts of Presentations at the Association of Clinical Scientists 139th Meeting Hershey, PA, May 15-18, 2019.

Donaldson K, Buchanich JM, Grigson PS, Deneke E, Donaldson K, Vrana KE, Sacks DB, Kuehn GJ, Cardamone D, Pesce A, Smiley S, Nickley J, Krock K, Thomas R, Wilkerson ML, Farag HA, Challa SR, Tice AM, Wolk DM, Prichard J, Grant ML, Regmi S, Kerbacher B, Quinton LE, Farag HA, Tice AM, Wolk DM, Olson J, Haynes A, Yu E, McCully KS, Assi J, Wong M, Zarrin-Khameh N, Nifong TP, Hawker CD, Carlton GT, Rivera JM, Foulis PR, Zuraw A, Morlote D, Peker D, Reddy V, Harada S, Crutchfield C, Zander D, Barbhuiya MA, Pederson EC, Straub ML, Scott SC, Neibauer TL, Salter WF, Creer MH, Zhu Y, Bornhorst JA, Theobald JP, Algeciras-Schimnich A, Cao L, Knox J, Hardy R, Texas HJ, McGuire MF, Hunter RL, Brown RE, Hicks J, Hicks J, Cai Z, Brown RE, Ali Y, Cheng KC, Katz SR, Ding Y, Vanselow DJ, Yakovlev MA, Lin AY, Clark DP, Vargas P, Xin X, Copper JE, Canfield VA, Ang KC, Wang Y, Xiao X, De Carlo F, van Rossum DB, La Rivière PJ, Newell J, Hossler C, Roche M, Warrick J, Phaeton R, Kesterson J, Donaldson K, Myers C, Barrios R, Mintz P, Robyak K, Hamilton C, McGhee P, Pederson C, Straub M, Scott S, Neibauer T, Salter W, Creer M, Zhu Y, Hamilton C, Robyak K, McGhee P, Pederson C, Straub M, Scott S, Neibauer T, Salter W, Creer M, Zhu Y, Singh N, Morlote D, Vnencak-Jones C, Yemelyanova A, Harada S, Shah M, Moghadamtousi SZ, Lan C, Duose D, Hu P, Esquenazi Y, Luthra R, Ballester LY, Koenig AN, Liu CG, Zhang J, Kalia A, Al-Habib A, Van Arsdall M, Dhingra S, Patel K, Tatevian N.

Ann Clin Lab Sci. 2019 May;49(3):403-416. No abstract available.

PMID:
31308044
2.

Question: In men with risk factors for coronary artery disease, does initiating lipid screening earlier than 35 years of age reduce cardiovascular events?

Smith J, McGhee P, Nguyen N, Palmer P.

J Okla State Med Assoc. 2018 Mar;111(3):560-561. No abstract available.

3.

Line-Trapping of Codling Moth (Lepidoptera: Tortricidae): A Novel Approach to Improving the Precision of Capture Numbers in Traps Monitoring Pest Density.

Adams CG, McGhee PS, Schenker JH, Gut LJ, Miller JR.

J Econ Entomol. 2017 Aug 1;110(4):1508-1511. doi: 10.1093/jee/tox147.

PMID:
28854646
4.
5.

Optimizing Aerosol Dispensers for Mating Disruption of Codling Moth, Cydia pomonella L.

McGhee PS, Miller JR, Thomson DR, Gut LJ.

J Chem Ecol. 2016 Jul;42(7):612-6. doi: 10.1007/s10886-016-0724-9. Epub 2016 Jul 1.

PMID:
27369280
6.

Alightment of Spotted Wing Drosophila (Diptera: Drosophilidae) on Odorless Disks Varying in Color.

Kirkpatrick DM, McGhee PS, Hermann SL, Gut LJ, Miller JR.

Environ Entomol. 2016 Feb;45(1):185-91. doi: 10.1093/ee/nvv155. Epub 2015 Oct 16.

7.

Aerosol emitters disrupt codling moth, Cydia pomonella, competitively.

McGhee PS, Gut LJ, Miller JR.

Pest Manag Sci. 2014 Dec;70(12):1859-62. doi: 10.1002/ps.3732. Epub 2014 Mar 10.

PMID:
24458561
8.

Haemophilus influenzae OxyR: characterization of its regulation, regulon and role in fitness.

Whitby PW, Morton DJ, Vanwagoner TM, Seale TW, Cole BK, Mussa HJ, McGhee PA, Bauer CY, Springer JM, Stull TL.

PLoS One. 2012;7(11):e50588. doi: 10.1371/journal.pone.0050588. Epub 2012 Nov 30.

9.

Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.

Mendes RE, Tsakris A, Sader HS, Jones RN, Biek D, McGhee P, Appelbaum PC, Kosowska-Shick K.

J Antimicrob Chemother. 2012 Jun;67(6):1321-4. doi: 10.1093/jac/dks069. Epub 2012 Mar 7.

PMID:
22398650
10.

Using the model of resource and time-based triage (MORTT) to guide scarce resource allocation in the aftermath of a nuclear detonation.

Casagrande R, Wills N, Kramer E, Sumner L, Mussante M, Kurinsky R, McGhee P, Katz L, Weinstock DM, Coleman CN.

Disaster Med Public Health Prep. 2011 Mar;5 Suppl 1:S98-110. doi: 10.1001/dmp.2011.16.

PMID:
21402818
11.

Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.

Clark C, McGhee P, Appelbaum PC, Kosowska-Shick K.

Antimicrob Agents Chemother. 2011 May;55(5):2344-51. doi: 10.1128/AAC.01602-10. Epub 2011 Feb 22.

12.

In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.

McGhee P, Clark C, Credito K, Beachel L, Pankuch GA, Appelbaum PC, Kosowska-Shick K.

Antimicrob Agents Chemother. 2011 May;55(5):2417-9. doi: 10.1128/AAC.01672-10. Epub 2011 Feb 22.

13.

Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital.

Kosowska-Shick K, Julian KG, McGhee PL, Appelbaum PC, Whitener CJ.

Diagn Microbiol Infect Dis. 2010 Sep;68(1):34-9. doi: 10.1016/j.diagmicrobio.2010.05.007.

PMID:
20727467
14.

Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.

Kosowska-Shick K, McGhee PL, Appelbaum PC.

Antimicrob Agents Chemother. 2010 May;54(5):1670-7. doi: 10.1128/AAC.00019-10. Epub 2010 Mar 1.

15.

General principles of attraction and competitive attraction as revealed by large-cage studies of moths responding to sex pheromone.

Miller JR, McGhee PS, Siegert PY, Adams CG, Huang J, Grieshop MJ, Gut LJ.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):22-7. doi: 10.1073/pnas.0908453107. Epub 2009 Dec 14.

16.

Comparative study of the mutant prevention concentrations of moxifloxacin, levofloxacin, and gemifloxacin against pneumococci.

Credito K, Kosowska-Shick K, McGhee P, Pankuch GA, Appelbaum PC.

Antimicrob Agents Chemother. 2010 Feb;54(2):673-7. doi: 10.1128/AAC.01353-09. Epub 2009 Dec 14.

17.

In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.

McGhee P, Clark C, Kosowska-Shick KM, Nagai K, Dewasse B, Beachel L, Appelbaum PC.

Antimicrob Agents Chemother. 2010 Jan;54(1):230-8. doi: 10.1128/AAC.01123-09. Epub 2009 Nov 2.

18.

Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.

Kosowska-Shick K, Clark C, Pankuch GA, McGhee P, Dewasse B, Beachel L, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Oct;53(10):4217-24. doi: 10.1128/AAC.00742-09. Epub 2009 Jul 20.

19.

Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.

Clark C, Kosowska-Shick K, McGhee P, Dewasse B, Beachel L, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Jul;53(7):3118-21. doi: 10.1128/AAC.00183-09. Epub 2009 May 11.

20.

Comparative antipneumococcal activities of sulopenem and other drugs.

Kosowska-Shick K, Ednie LM, McGhee P, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Jun;53(6):2239-47. doi: 10.1128/AAC.01531-08. Epub 2009 Mar 23.

21.

Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.

Kosowska-Shick K, McGhee P, Appelbaum PC.

Antimicrob Agents Chemother. 2009 May;53(5):2176-80. doi: 10.1128/AAC.01566-08. Epub 2009 Feb 23.

22.

Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs.

Clark C, Ednie LM, Lin G, Smith K, Kosowska-Shick K, McGhee P, Dewasse B, Beachel L, Caspers P, Gaucher B, Mert G, Shapiro S, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Apr;53(4):1353-61. doi: 10.1128/AAC.01619-08. Epub 2009 Feb 2.

23.

In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types.

Bhagwat SS, McGhee P, Kosowska-Shick K, Patel MV, Appelbaum PC.

Antimicrob Agents Chemother. 2009 Feb;53(2):811-3. doi: 10.1128/AAC.01150-08. Epub 2008 Nov 24. Erratum in: Antimicrob Agents Chemother. 2009 Mar;53(3):1298.

24.

Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center.

Kosowska-Shick K, Ednie LM, McGhee P, Smith K, Todd CD, Wehler A, Appelbaum PC.

Antimicrob Agents Chemother. 2008 Dec;52(12):4510-3. doi: 10.1128/AAC.01073-08. Epub 2008 Oct 6.

25.

IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response.

Rubinstein MP, Lind NA, Purton JF, Filippou P, Best JA, McGhee PA, Surh CD, Goldrath AW.

Blood. 2008 Nov 1;112(9):3704-12. doi: 10.1182/blood-2008-06-160945. Epub 2008 Aug 8.

26.

In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.

Clark C, Smith K, Ednie L, Bogdanovich T, Dewasse B, McGhee P, Appelbaum PC.

Antimicrob Agents Chemother. 2008 Jan;52(1):77-84. Epub 2007 Oct 15.

27.

Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agents.

Bogdanovich T, Clark C, Kosowska-Shick K, Dewasse B, McGhee P, Appelbaum PC.

Antimicrob Agents Chemother. 2007 Nov;51(11):4191-5. Epub 2007 Sep 17.

28.
29.

Oblique incidence reflection imaging of live cells: improving contrast and image quality with an objective mask.

Landry S, DeGagne LH, McGhee PL, Keeler WJ.

J Microsc. 2007 Aug;227(Pt 2):185-9.

30.

Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents.

Kosowska-Shick K, Credito KL, Pankuch GA, DeWasse B, McGhee P, Appelbaum PC.

Antimicrob Agents Chemother. 2007 Feb;51(2):770-3. Epub 2006 Nov 20.

31.

Activity of LBM415 compared to those of 11 other agents against Haemophilus species.

Bogdanovich T, Smith KA, Clark C, Pankuch GA, Lin G, McGhee P, Dewasse B, Appelbaum PC.

Antimicrob Agents Chemother. 2006 Jul;50(7):2323-9.

32.

Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.

Kosowska-Shick K, Credito K, Pankuch GA, Lin G, Bozdogan B, McGhee P, Dewasse B, Choi DR, Ryu JM, Appelbaum PC.

Antimicrob Agents Chemother. 2006 Jun;50(6):2064-71.

33.

Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes.

Kosowska-Shick K, Clark C, Credito K, McGhee P, Dewasse B, Bogdanovich T, Appelbaum PC.

Antimicrob Agents Chemother. 2006 Feb;50(2):765-9.

34.

Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin.

Kosowska K, Hoellman DB, Lin G, Clark C, Credito K, McGhee P, Dewasse B, Bozdogan B, Shapiro S, Appelbaum PC.

Antimicrob Agents Chemother. 2005 May;49(5):1932-42.

35.
36.

Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.

Kosowska K, Credito K, Pankuch GA, Hoellman D, Lin G, Clark C, Dewasse B, McGhee P, Jacobs MR, Appelbaum PC.

Antimicrob Agents Chemother. 2004 Nov;48(11):4113-9.

37.

Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.

Matic V, Kosowska K, Bozdogan B, Kelly LM, Smith K, Ednie LM, Lin G, Credito KL, Clark CL, McGhee P, Pankuch GA, Jacobs MR, Appelbaum PC.

Antimicrob Agents Chemother. 2004 Nov;48(11):4103-12.

38.

In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 beta-lactams.

Clark C, Kosowska K, Bozdogan B, Credito K, Dewasse B, McGhee P, Jacobs MR, Appelbaum PC.

Diagn Microbiol Infect Dis. 2004 May;49(1):31-6.

PMID:
15135497
39.

Gender differences in the reliability of the EPQ? A bootstrapping approach.

Miles JN, Shevlin M, McGhee PC.

Br J Psychol. 1999 Feb;90 ( Pt 1):145-54.

PMID:
10085551
40.

Rx: laughter.

McGhee P.

RN. 1998 Jul;61(7):50-3. Review. No abstract available.

PMID:
9687818
41.

The Siemens virtual wedge.

McGhee P, Chu T, Leszczynski K, Dunscombe P.

Med Dosim. 1997 Spring;22(1):39-41.

PMID:
9136106
42.

Anthropomorphic phantom measurements for the validation of a treatment planning system.

Dunscombe P, McGhee P, Lederer E.

Phys Med Biol. 1996 Mar;41(3):399-411.

PMID:
8778822
43.

Radiation dose associated with spiral computed tomography.

McGhee PL, Humphreys S.

Can Assoc Radiol J. 1994 Apr;45(2):124-9.

PMID:
8149267
44.

How humor helps nurses manage job stress.

McGhee PE.

J Pract Nurs. 1993 Sep;43(3):37-40. No abstract available.

PMID:
8410721
45.

An efficient approach to routine TL dosimetry.

McGhee P, Humphreys S, Dunscombe P.

Med Dosim. 1993 Winter;18(4):187-91.

PMID:
8311914
46.
47.

Energy-dispersive measurements of the K alpha 3, KM1, K beta 1, and K beta 2 x-ray intensities relative to the K alpha 1 intensity in lead and uranium.

Campbell JL, McGhee PL, Maxwell JA, Ollerhead RW, Whittaker B.

Phys Rev A Gen Phys. 1986 Feb;33(2):986-993. No abstract available.

PMID:
9896711
48.

The Role of Identity of the Victim in the Development of Disparagement Humor.

McGhee PE, Duffey NS.

J Gen Psychol. 1983 Apr;108(2):257-270. doi: 10.1080/00221309.1983.9711499.

PMID:
28150554
49.

Adjustment of early parenthood: the role of accuracy of preparenthood experiences.

Kach JA, Mcghee PE.

J Fam Issues. 1982 Sep;3(3):375-88.

PMID:
12338437
50.

Test of an information-processing model of humor: physiological response changes during problem- and riddle-solving.

Goldstien JH, Harmon J, McGhee PE, Karasik R.

J Gen Psychol. 1975 Jan;92(1st Half):59-68.

PMID:
1113088

Supplemental Content

Loading ...
Support Center